Mannatech has proprietary rights to their glyconutrient technology. Mannatech has won patent infringement judgments against five companies accused of using the firm’s patented glyconutrients in products.
As the Dallas Business Journal reported in May, Mannatech previously had 17 competing products pulled off the shelves for using the patented technology.Mannatech said Thursday it won judgments against the five companies — Micro Health Solutions, Wy’s Enterprises, Florida Nutri Labs, Angel Care USA and New Sun — after accusing the companies of manufacturing, using or selling products that infringe on its nutrient patents.
Wednesday, July 07, 2010
Friday, March 19, 2010
Glyconutrient Product Patents Defended With Latest Legal Action Against Multiple Companies
Mannatech, Inc. announced it has filed a complaint against seven independent companies for infringement on Mannatech`s patents (U.S. Patents 6,929,807; 7,157,431; 7,199,104; and 7,202,220). This complaint brings patent infringement claims against the following companies (products); Country Life, LLC, Country Life Manufacturing, LLC (Realfood OrganicsHer Daily Nutrition, His Daily Nutrition, Your Daily Nutrition, Ultimate Daily Nutrition and Glyconutrient Complex) ; EvenBetterNow, LLC, (EBN Glyconutrients) ;Micro Health Solutions, LLC, (Glyco Balance) ; New Sun, Inc., (Salmana) ; Oasis Advanced Wellness, LLC, (GlycoEssential 7) ;Roex, Inc. (Cell Talk) ; VDF Futurecueticals, Inc. (GlycoBerry 8).
Thursday, January 14, 2010
Randomized, Double-Blind, Controlled Human Study Finds Mannatech’s Ambrotose® Complex Improves Cognition and Well-Being*
The results of a randomized, double-blind, placebo-controlled study shows healthy middle-aged adults who took one teaspoon of Ambrotose® complex1 twice daily performed significantly better on memory tasks and were overall more positive in their mood.2 *
Drs. Talitha Best and Eva Kemps of Flinders University in Adelaide, Australia, and Dr. Janet Bryan of the University of South Australia in Adelaide, Australia, published their findings of the 12-week study in the January 2010 issue of Developmental Neuropsychology, a peer-reviewed scientific journal.
“This rigorous double-blind, placebo-controlled study confirms important biological effects of Mannatech's flagship and proprietary product, Ambrotose complex,” said Dr. Robert A. Sinnott, MNS, PhD, co-chief executive officer and chief science officer of Mannatech. “The significantly better performance on memory tasks and positive effects on mood experienced by the study participants who consumed Ambrotose complex is congruent with beneficial effects on brain functions.”*
Drs. Talitha Best and Eva Kemps of Flinders University in Adelaide, Australia, and Dr. Janet Bryan of the University of South Australia in Adelaide, Australia, published their findings of the 12-week study in the January 2010 issue of Developmental Neuropsychology, a peer-reviewed scientific journal.
“This rigorous double-blind, placebo-controlled study confirms important biological effects of Mannatech's flagship and proprietary product, Ambrotose complex,” said Dr. Robert A. Sinnott, MNS, PhD, co-chief executive officer and chief science officer of Mannatech. “The significantly better performance on memory tasks and positive effects on mood experienced by the study participants who consumed Ambrotose complex is congruent with beneficial effects on brain functions.”*
The abstract of the study states that: “Before and after this supplementation period, participants completed alternate forms of standardized tests of cognition and self-report measures of well-being. Significant beneficial and longer-term effects of saccharide supplementation were found for memory performance and indicators of well-being. The potential for these nutrients to optimize cognitive function and well-being in older adults warrants on-going investigation.”2 *
“Right now, commercial development of compounds to enhance cognitive functioning is one of the hottest areas of biomedical research,” Sinnott continued. “While most research focuses around synthetic compounds, Mannatech's Ambrotose complex is comprised of ingredients that are isolated and purified from renewable natural sources, primarily plants. Mannatech has pioneered the field of nutritional glycobiology since 1996, and we will continue to be a leader in the future.”
1 Mannatech, Incorporated donated the Ambrotose complex and placebo.
2 Best T, Kemps E, Bryan J. Saccharide effects on cognition and well-being in middle-aged adults: A randomized controlled trial. Developmental Neuropsychology 2010; 35(1): 66 -80.
*This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
Mannatech currently holds more than 45 patents in 30 countries for the technology related to Ambrotose complex.
In addition, many of Mannatech’s products are based on Real Food TechnologySM solutions, which provide consumers with products that contain standardized levels of natural and plant-sourced nutrients at nutritionally effective levels. Food-sourced ingredients are chosen from those scientifically proven to most benefit the human body. Mannatech offers the best alternative to synthetic vitamin and mineral products and so-called “super-juice” products.
Individuals interested in Mannatech’s products or in exploring its business opportunity can learn more at New.Mannatech.com.
Wednesday, November 25, 2009
Mannatech's Educational Web Site Receives Web Health Merit Award
Mannatech's educational Web site, MannatechScience.org, has received a merit Web Health Award.
The Web Health Awards program recognizes the best Web-based health-related content for consumers and professionals. The program, held twice a year, reviews Web sites and bestows a seal of quality for those that provide reliable health information. This seal of quality should remind consumers that a panel of international health information and Internet experts have reviewed the site and approved it for accuracy, success in reaching its targeted audience and overall quality.
“We are honored to have the work of our scientific services team recognized,” said Dr. Robert Sinnott, Mannatech’s chief science officer and senior vice president. “Our goal at Mannatech is not only to produce innovative wellness products, but to provide education and scientific validation that confirms the benefits of our products. We are continually learning through research relationships with academic and corporate partners; it’s important to share that knowledge with our independent sales Associates and consumers.”
Read more...
The Web Health Awards program recognizes the best Web-based health-related content for consumers and professionals. The program, held twice a year, reviews Web sites and bestows a seal of quality for those that provide reliable health information. This seal of quality should remind consumers that a panel of international health information and Internet experts have reviewed the site and approved it for accuracy, success in reaching its targeted audience and overall quality.
“We are honored to have the work of our scientific services team recognized,” said Dr. Robert Sinnott, Mannatech’s chief science officer and senior vice president. “Our goal at Mannatech is not only to produce innovative wellness products, but to provide education and scientific validation that confirms the benefits of our products. We are continually learning through research relationships with academic and corporate partners; it’s important to share that knowledge with our independent sales Associates and consumers.”
Read more...
Friday, October 09, 2009
Courts Recognize Mannatech as Owner of Glyconutrient Technology
Mannatech, Incorporated announced today the company has secured a second injunction in its ongoing efforts to protect its patented glyconutrient products Ambrotose®complex and Advanced Ambrotose™formula.
“Mannatech has demonstrated that it will fight to protect its intellectual property. The Court’s decision is further notice to all interested parties that we will do what is necessary to support our products and our independent sales Associates in the field,” said Keith Clark, senior vice president and general counsel of Mannatech.
Mannatech has vigorously pursued patent infringement cases against companies to stop their manufacture and sale of infringing products. The company’s first victory came last year, when Mannatech won on all patent and trademark infringement claims brought against Glycobiotics International, Inc. As part of the final judgment in that case, Glycobiotics was ordered to stop production of its infringing product Glycomannan and deliver any existing product to Mannatech for destruction.
The United States District Court for the Northern District of Texas, Dallas Division, has entered a Final Judgment and Permanent Injunction against Boston Mountain Laboratories, Inc., which bans Boston Mountain Laboratories from manufacturing or selling BML Glyconutrient Formula, Glyco-8, Glycoessentials, Glyco-Essence, Glyconutrients, MG-3, and MG-3c for the duration of Mannatech’s U.S. Patents 6,929,807; 7,157,431; 7,196,064; 7,199,104; and 7,202,220.
The courts have recognized that Mannatech is the rightful owner of the patented technology concerning “Compositions of Plant Technology as Dietary Supplements.” As part of the final judgment in this case, Boston Mountain Laboratories, plus its officers, agents, employees, and any persons acting in concert or participation with the company, are prohibited from making, using, selling, or otherwise distributing within the United States any of the accused products or any colorable imitations thereof.“Mannatech has demonstrated that it will fight to protect its intellectual property. The Court’s decision is further notice to all interested parties that we will do what is necessary to support our products and our independent sales Associates in the field,” said Keith Clark, senior vice president and general counsel of Mannatech.
Mannatech has vigorously pursued patent infringement cases against companies to stop their manufacture and sale of infringing products. The company’s first victory came last year, when Mannatech won on all patent and trademark infringement claims brought against Glycobiotics International, Inc. As part of the final judgment in that case, Glycobiotics was ordered to stop production of its infringing product Glycomannan and deliver any existing product to Mannatech for destruction.
Subscribe to:
Posts (Atom)